Identification | Back Directory | [Name]
Dehydroheliobuphthalmin | [CAS]
103001-05-4 | [Synonyms]
(E)-(1,3-Benzodioxol-5-ylmethyl)(1,3-benzodioxol-5-ylmethylene)butanedioic acid dimethyl ester Butanedioic acid, (1,3-benzodioxol-5-ylmethyl)(1,3-benzodioxol-5-ylmethylene)-, dimethyl ester, (E)- (9CI) | [Molecular Formula]
C22H20O8 | [MDL Number]
MFCD17214937 | [MOL File]
103001-05-4.mol | [Molecular Weight]
412.389 |
Chemical Properties | Back Directory | [Boiling point ]
582.3±50.0 °C(Predicted) | [density ]
1.360±0.06 g/cm3(Predicted) | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
Powder |
Hazard Information | Back Directory | [Description]
Dehydroheliobuphthalmin has significant neuroprotective activities against glutamate-
induced neurotoxicity. | [Uses]
(7E)-7,8-Dehydroheliobuphthalmin is a lignan derivative from Platycladus orientalis[1]. | [References]
[1] Li, Gang, et al. Separation and extraction of lignans derivatives from Platycladus orientalis. Patent CN113666902. 2021-11-19. |
|
Company Name: |
BioBioPha Co., Ltd.
|
Tel: |
0871-65217109 13211707573; |
Website: |
http://www.biobiopha.com |
|